Swiss pharma giant Novartis’ shares edged up 2% to 130.00 in early trading as the company reported third quarter 2026 ...

US clinical-stage biopharma Corxel Pharmaceuticals, which is focused on developing innovative oral therapies for obesity and ...

Chiesi Global Rare Diseases, the rare diseases business unit of Italy’s family-run Chiesi Group, announced three poster ...

German pharma and life sciences company Merck KGaA today announced new two-year follow-up results from the Phase III MANEUVER ...

China is emerging as an innovation hub in the rapidly diversifying global obesity drug landscape, with domestic drugmakers ...

US precision oncology company IDEAYA Biosciences and partner Servier presented updated data from three trials of the oral PKC ...

Cambridge, USA based Spero Therapeutics, which is focused on developing advanced medicines for serious immune-mediated ...

Pathos AI, a clinical-stage AI and technology company advancing its own therapeutic pipeline of drugs, today announced the closing of a $237 million Series E financing round at a post-money valuation ...

The US Centers for Medicare and Medicaid Services (CMS) has released the final guidelines for implementation of the GLOBE ...

Swiss pharma major Roche (ROG: SIX) has reported that its experimental lung cancer drug divarasib reduced the risk of death ...

Medicines that bring cancer cells into contact with immune cells are becoming part of treatment for several blood cancers and small cell lung cancer. Known as T-cell engagers, they are also being ...

Shares in Tango Therapeutics fell nearly 18% to $22.91 on Friday after the US biotech presented updated Phase I/II data for ...